Literature DB >> 17559602

Prevalence and correlates of comorbidity 8 years after a first psychotic episode.

S Farrelly1, M G Harris, L P Henry, R Purcell, A Prosser, O Schwartz, H Jackson, P D McGorry.   

Abstract

OBJECTIVE: While rates and correlates of comorbidity have been investigated in the early course of psychosis, little is known about comorbidity in the medium-to-longer term or its relationship with outcome.
METHOD: A total of 182 first-episode psychosis (FEP) patients who met DSM-IV criteria for a current psychotic disorder 8 years after index presentation were grouped according to concurrent comorbidity [no concurrent axis I disorder; concurrent substance use disorder (SUD); other concurrent axis I disorder; concurrent SUD and other axis I disorder]. Outcomes were compared between groups controlling for relevant covariates.
RESULTS: As much as 39% met criteria for one or more concurrent axis 1 diagnoses. Comorbidity was associated with greater severity of general psychopathology, but not with measures of functioning, treatment or negative symptoms.
CONCLUSION: Specific combinations of comorbid disorders may influence patterns of psychotic symptomatology. Routine examination of axis I disorders is warranted in the ongoing management of psychosis.

Entities:  

Mesh:

Year:  2007        PMID: 17559602     DOI: 10.1111/j.1600-0447.2006.00922.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  5 in total

1.  A qualitative study of career exploration among young adult men with psychosis and co-occurring substance use disorder.

Authors:  Alison Luciano; Elizabeth A Carpenter-Song
Journal:  J Dual Diagn       Date:  2014

2.  The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis.

Authors:  Melissa A Weibell; Wenche Ten Velden Hegelstad; Bjørn Auestad; Jørgen Bramness; Julie Evensen; Ulrik Haahr; Inge Joa; Jan Olav Johannessen; Tor Ketil Larsen; Ingrid Melle; Stein Opjordsmoen; Bjørn Rishovd Rund; Erik Simonsen; Per Vaglum; Thomas McGlashan; Patrick McGorry; Svein Friis
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

Review 3.  Substance use disorder among people with first-episode psychosis: a systematic review of course and treatment.

Authors:  Jennifer P Wisdom; Jennifer I Manuel; Robert E Drake
Journal:  Psychiatr Serv       Date:  2011-09       Impact factor: 3.084

Review 4.  How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association.

Authors:  Amélie M Achim; Michel Maziade; Eric Raymond; David Olivier; Chantal Mérette; Marc-André Roy
Journal:  Schizophr Bull       Date:  2009-12-03       Impact factor: 9.306

5.  Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis.

Authors:  Johanna Koskinen; Johanna Löhönen; Hannu Koponen; Matti Isohanni; Jouko Miettunen
Journal:  Schizophr Bull       Date:  2009-04-22       Impact factor: 9.306

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.